Heart Attack Patients Given Worthless Meds? (Don’t Be Next)
If you weren’t serious about your health before a heart attack, you get awfully serious about it after.
You start eating better… exercising more… and taking all of your meds like clockwork.
Because you’re desperate to prevent that next heart attack – the one that could kill you.
But disturbing news is emerging about a common class of drugs being given to heart attack patients.
They don’t work. They may be more harm than they’re worth.
And if you’ve had a heart attack, there’s a good chance they’re sitting in your medicine cabinet right now.
The theory behind beta blockers is pretty straightforward.
They slow your heart rate and lower your blood pressure, so your heart doesn’t have to work so hard.
So it almost makes sense why they’d be prescribed to folks after a heart attack.
Except they just… don’t… work.
A new meta-analysis looked at studies involving nearly 20,000 patients who had heart attacks – about half of whom were given beta blockers as part of their treatment plan.
Then, researchers looked at people with what is known as “preserved left ventricular ejection fraction” (LVEF).
Basically, that means your heart’s main pumping chamber is still working effectively – and previous research has shown this is the case for the majority of heart attack patients.
Well, it turns out there was no difference in mortality whatsoever between people who got beta blockers and people who didn’t.
Zip. Nada.
Beta blockers also didn’t reduce the odds of future heart attacks or heart failure.
So beta blockers did nothing to help these heart attack patients. But they do an excellent job of causing side effects, like dizziness, sleep problems, or trouble performing in the bedroom.
Like I said… they’re probably more trouble than they’re worth.
If you’ve had a heart attack, ask your care team if you have preserved LVEF. And if you’ve been prescribed a beta blocker, ask if you truly need it.
That beta blocker probably isn’t going to add a single day to your life – and it could cause plenty of other problems in the bargain.
View Sources
Medscape. (2026, January 12). Beta-blockers after MI may not offer much in preserved EF. Medscape. https://www.medscape.com/viewarticle/beta-blockers-after-mi-may-not-offer-much-preserved-ef-2026a10000vy

